The Influence of The Ear Popper on Serous Otitis Media and on the Accompanying Conductive Hearing Loss in Children
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment
Enrollment
Phase
Phase
- Phase 4
Contacts and Locations
Study Contact
Study Contact
- Name: Yael Oestreicher, MD
- Phone Number: 972-3-6974517
- Email: dkyo@barak-online.net.il
Study Contact Backup
- Name: Ari DeRowe, MD
- Phone Number: 972-3-6974517
Study Locations
-
-
-
Tel-Aviv, Israel
- Recruiting
- ENT Unit, Dana Children's Hospital, Tel-Aviv Medical Center
-
Contact:
- Yael Oestreicher, MD
- Phone Number: 972-3-6974517
- Email: dkyo@barak-online.net.il
-
Principal Investigator:
- Yael Oestreicher, MD
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Serous Otitis Media for More Then 3 months
- Conductive Hearing Loss of More Then 15 decibels.
- Tympanometry type B or C.
Exclusion Criteria:
- No History of Tympanostomy Tube Insertion or Adenoidectomy
- No Cranio or Facial Malformations
- No Acute Upper Respiratory Tract Infection or Acute Otitis Media
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
|---|
|
Audiometry and tympanometry test results at at 7 weeks and 3 months from beginning of use of the ear popper.
|
|
Otoscopic findings at at 7 weeks and 3 months from beginning of use of the ear popper.
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
|---|
|
Hearing improvement at 7 weeks and 3 months from the beginning of the trial.
|
|
Rate of referrals for tympanostomy tube insertion at 3 months
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: Yael Oestreicher, MD, Tel Aviv Medical Center
Study record dates
Study Major Dates
Study Start
Study Start
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Estimate)
First Posted
Study Record Updates
Last Update Posted (Estimate)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- TASMC06YO3567CTIL
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.